Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Gynecologic 1 Breast 1

Conditions

Sarcoma, Ewing 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 30 Doxorubicin 24 Biopsy 24 pembrolizumab 22 Temozolomide 22 Radiotherapy 19 X-Rays 18 Radiation 18 Nivolumab 14 Vincristine 13 Irinotecan 13 fludarabine 12 atezolizumab 12 Phantoms, Imaging 12 Ifosfamide 12 Gemcitabine 12 cabozantinib 10 Bevacizumab 9 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Paclitaxel 8 Ipilimumab 8 Immunoglobulin G 8 Etoposide 8 Dactinomycin 7 Carboplatin 7 palbociclib 6 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

romiplostim × Sarcoma × 90 days × Clear all

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡